Gene · 23642
Papers1,503
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,503
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Retraction: "Downregulation of long noncoding RNA SNHG1 inhibits cell proliferation, metastasis, and invasion by suppressing the Notch-1 signaling pathway in pancreatic cancer". | J Cell Biochem | 2024 | 38591427 | PubTator, text mining | PubMed |
| Proceedings of the CIMAGO Congress - Environment, Genetics and Oncobiology in the 21st Century - Challenges and Opportunities. | Medicine (Baltimore) | 2024 | 38579039 | PubTator, text mining | PubMed |
| lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p/IGF2BP2 axis. | Heliyon | 2024 | 38545199 | PubTator, text mining | PubMed |
| DNA Methylation of a Group of Long Non-Coding RNA Genes at Different Stages of Ovarian Cancer Dissemination. | Bull Exp Biol Med | 2024 | 38492100 | PubTator, text mining | PubMed |
| Correction: LncRNA SNHG1 and RNA binding protein hnRNPL form a complex and coregulate CDH1 to boost the growth and metastasis of prostate cancer. | Cell Death Dis | 2024 | 38485933 | PubTator, text mining | PubMed |
| The Potential of Targeting Autophagy-Related Non-coding RNAs in the Treatment of Alzheimer's and Parkinson's Diseases. | Cell Mol Neurobiol | 2024 | 38461204 | PubTator, text mining | PubMed |
| Tumorigenesis of basal muscle invasive bladder cancer was mediated by PTEN protein degradation resulting from SNHG1 upregulation. | J Exp Clin Cancer Res | 2024 | 38365726 | PubTator, text mining | PubMed |
| Long noncoding RNA SNHG1 promotes breast cancer progression by regulating the miR-641/RRS1 axis. | Sci Rep | 2024 | 38331968 | PubTator, text mining | PubMed |
| An in silico approach to identify potential downstream targets of miR-153 involved in Alzheimer's disease. | Front Genet | 2024 | 38299037 | PubTator, text mining | PubMed |
| Interaction between long noncoding RNA and microRNA in lung inflammatory diseases. | Immun Inflamm Dis | 2024 | 38270295 | PubTator, text mining | PubMed |
| The Role of Human Papilloma Virus (HPV) in Primary Lung Cancer Development: State of the Art and Future Perspectives. | Life (Basel) | 2024 | 38255725 | PubTator, text mining | PubMed |
| The implications for urological malignancies of non-coding RNAs in the the tumor microenvironment. | Comput Struct Biotechnol J | 2024 | 38249783 | PubTator, text mining | PubMed |
| The Impact of Long Noncoding RNAs in Tissue Regeneration and Senescence. | Cells | 2024 | 38247811 | PubTator, text mining | PubMed |
| LncRNA SNHG1 alleviates myocardial ischaemia-reperfusion injury by regulating the miR-137-3p/KLF4/TRPV1 axis. | ESC Heart Fail | 2024 | 38234046 | PubTator, text mining | PubMed |
| Relationship between long non-coding RNAs and Hippo signaling pathway in gastrointestinal cancers; molecular mechanisms and clinical significance. | Heliyon | 2024 | 38226210 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in metabolic reprogramming of gastrointestinal cancer cells. | Cancer Cell Int | 2024 | 38184562 | PubTator, text mining | PubMed |
| The regulatory relationship between transcription factor STAT3 and noncoding RNA. | Cell Mol Biol Lett | 2024 | 38172648 | PubTator, text mining | PubMed |
| Current evidence and therapeutic implication of PANoptosis in cancer. | Theranostics | 2024 | 38169587 | PubTator, text mining | PubMed |
| Comprehensive analysis of m6A reader YTHDF2 prognosis, immune infiltration, and related regulatory networks in hepatocellular carcinoma. | Heliyon | 2024 | 38163150 | PubTator, text mining | PubMed |
| Subcellular RNA distribution and its change during human embryonic stem cell differentiation. | Stem Cell Reports | 2024 | 38134924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23642/papers?page=6